|
Market Closed -
Nasdaq
00:00:00 07/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 79.57 USD | +1.63% |
|
-4.96% | +21.85% |
| 10-06 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-21 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
| Market Cap | 525M 467M 437M 396M 747M 50.64B 753M 5.25B 2.04B 25.83B 1.97B 1.93B 83.12B | P/E 2026 * |
-32.1x | P/E 2027 * | -31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 407M 361M 338M 306M 578M 39.19B 583M 4.06B 1.58B 19.99B 1.53B 1.49B 64.33B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.5x |
| Free-Float |
76.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MNPR | Delayed | |
CBOE
| MNPR | Real-time | |
|
Deutsche Boerse AG
| 1IY0 | Delayed | |
|
Boerse Muenchen
| 1IY0 | Real-time | |
|
Tradegate
| 1IY0 | Real-time | |
|
Börse Stuttgart
| 1IY0 | Delayed |
| 1 day | +1.63% | ||
| 1 week | -4.96% | ||
| Current month | -0.13% | ||
| 1 month | -32.32% | ||
| 3 months | -18.63% | ||
| 6 months | +44.33% | ||
| Current year | +21.85% |
| 1 week | 75.32 |  | 82.66 |
| 1 month | 75.32 | | 117.61 |
| Current year | 50.07 | | 124.82 |
| 1 year | 50.07 | | 124.82 |
| 3 years | 1.37 | | 124.82 |
| 5 years | 1.37 | | 124.82 |
| 10 years | 1.37 | | 240 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 42 | 01/12/2014 | |
Quan Anh Vu
DFI | Director of Finance/CFO | 54 | 03/03/2025 |
Jeffrey Kent
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 42 | 01/12/2014 | |
| Chairman | 73 | 01/12/2014 | |
Raymond Anderson
BRD | Director/Board Member | 84 | 01/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Operating Officer | 10,712 | 0.1596% | ||
| 30/09/26 | Exercice | Founder | 23,946 | 0.3568% | ||
| 30/09/26 | Exercice | Chief Financial Officer | 1,408 | 0.0210% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.63% | -4.96% | -19.94% | +2,798.72% | 525M | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| +2.76% | -1.16% | +23.05% | +83.03% | 56.95B | |
| +0.24% | -1.37% | +4.08% | +37.22% | 48.3B | |
| -3.76% | -0.93% | +327.90% | +691.25% | 44.51B | |
| -2.30% | -4.06% | +25.82% | +31.42% | 43.8B | |
| +0.31% | -1.15% | +5.50% | +112.56% | 41.12B | |
| -0.11% | +2.30% | +9.19% | +58.68% | 31.07B | |
| +4.51% | +8.43% | +37.27% | +34.97% | 28.97B | |
| -1.96% | -3.38% | -9.25% | -12.85% | 24.53B | |
| Average | +0.55% | -0.83% | +45.30% | +392.92% | 39.41B | |
| Weighted average by Cap. | +0.77% | -0.50% | +56.48% | +137.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 28.26M 25.1M 23.51M 21.29M 40.15M 2.72B 40.48M 282M 110M 1.39B 106M 104M 4.47B |
| Net income | -21.46M -19.06M -17.86M -16.17M -30.5M -2.07B -30.75M -214M -83.34M -1.05B -80.56M -78.83M -3.39B | -26.62M -23.64M -22.14M -20.05M -37.82M -2.56B -38.13M -266M -103M -1.31B -99.9M -97.76M -4.21B |
| Net Debt | -119M -105M -98.8M -89.48M -169M -11.44B -170M -1.19B -461M -5.84B -446M -436M -18.78B | -145M -128M -120M -109M -205M -13.93B -207M -1.44B -561M -7.11B -543M -531M -22.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | $79.57 | +1.63% | 301,958 |
| 05/10/26 | $78.29 | +0.41% | 128,261 |
| 02/10/26 | $77.97 | 0.00% | 107,622 |
| 01/10/26 | $77.97 | -2.13% | 130,810 |
| 30/09/26 | $79.67 | -0.41% | 226,312 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MNPR Stock
Select your edition
All financial news and data tailored to specific country editions
